XIAP induces inflammation and promotes colorectal cancer progression

Colorectal cancer (CRC) is one of the most diagnosed malignancies worldwide, with chronic inflammation playing a critical role in its pathogenesis and progression. Surgery represents the primary treatment option, though some patients suffer from relapse, leading to considerable morbidity and mortality. A better molecular understanding of CRC pathogenesis is therefore essential for identifying patients at increased risk of recurrence and improving clinical management. Here we identified the X-linked inhibitor of apoptosis protein (XIAP) as an independent predictor of overall survival in primary resected CRC patients. To model CRC patients with low versus high XIAP expression, we established conditional mouse lines for intestinal epithelial cell (IECs)-specific Xiap knock-out and XIAP knock-in, and employed a colitis-associated murine model for CRC. We found that XIAP promotes inflammatory signalling and exacerbates colitis-driven colorectal tumorigenesis by shaping a distinct tumor inflammatory microenvironment characterized by increased immune-cell infiltration, including neutrophils, and enhanced vascularisation. The pro-inflammatory role of XIAP was further validated in CRC patient-derived organoids and human CRC tumor specimens. Collectively, our findings identify XIAP as a potential biomarker of CRC-associated inflammation and a candidate marker for identifying patients at increased risk of disease recurrence. Moreover, these results provide a rationale for exploring XIAP-targeting strategies as a potential component of multimodal therapeutic approaches for CRC.

Authors

Institutions

Publication Details

Journal
Cell Death and Disease
Published
2026-11-02
DOI
https://doi.org/10.1038/s41419-026-09391-9
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

XIAP induces inflammation and promotes colorectal cancer progression

Naita Maren Wirsik, J Paul Werthenbach, Melanie Fritsch, Lars Mortimer Schiffmann et al.
Cell Death and Disease
Colorectal Cancer Treatments and Studies
article

XIAP induces inflammation and promotes colorectal cancer progression

Naita Maren Wirsik, J Paul Werthenbach, Melanie Fritsch, Lars Mortimer Schiffmann, Georg Dieplinger, Florian Gebauer, Ulrike Göbel, Nikolai Schleußner, Hakan Alakus, Su Ir Lyu, Ali Taleb Abdallah, Domagoj Vucic, Christiane J. Bruns, Hamid Kashkar, Fabian Schorn, Uraz Yasar, Pia Nora Broxtermann, Frank Thomas Wunderlich, Stephanie Theresa Jünger, Hans Friedrich Fuchs, Thomas Zander, Johanna Stachelscheid, Marie‐Christine Albert, Karl Knipper, Mila Daoud, Heike Goebel, Claudia Maria Wunderlich, Jens Michael Seeger, Christian Goddemeier, Alexander Quaas, Hans A. Schlößer, M. Siebenbürger, Thomas Schmidt
article en

Abstract

Colorectal cancer (CRC) is one of the most diagnosed malignancies worldwide, with chronic inflammation playing a critical role in its pathogenesis and progression. Surgery represents the primary treatment option, though some patients suffer from relapse, leading to considerable morbidity and mortality. A better molecular understanding of CRC pathogenesis is therefore essential for identifying patients at increased risk of recurrence and improving clinical management. Here we identified the X-linked inhibitor of apoptosis protein (XIAP) as an independent predictor of overall survival in primary resected CRC patients. To model CRC patients with low versus high XIAP expression, we established conditional mouse lines for intestinal epithelial cell (IECs)-specific Xiap knock-out and XIAP knock-in, and employed a colitis-associated murine model for CRC. We found that XIAP promotes inflammatory signalling and exacerbates colitis-driven colorectal tumorigenesis by shaping a distinct tumor inflammatory microenvironment characterized by increased immune-cell infiltration, including neutrophils, and enhanced vascularisation. The pro-inflammatory role of XIAP was further validated in CRC patient-derived organoids and human CRC tumor specimens. Collectively, our findings identify XIAP as a potential biomarker of CRC-associated inflammation and a candidate marker for identifying patients at increased risk of disease recurrence. Moreover, these results provide a rationale for exploring XIAP-targeting strategies as a potential component of multimodal therapeutic approaches for CRC.

Cell Death and DiseaseVol. 17(1)
University of Cologne (DE), Genentech (US), Heidelberg University (DE), University Hospital Heidelberg (DE), Düsseldorf University Hospital (DE), Max Planck Institute for Metabolism Research (DE), Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE), University Hospital Cologne (DE), Heinrich Heine University Düsseldorf (DE)
Good health and well-being
Openalex Percentile: Top 17%
Colorectal Cancer Treatments and Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon